BioMed Research International

Chemo-Radiotherapy for Multimodality Treatment of Tumors 2022


Publishing date
01 Dec 2022
Status
Closed
Submission deadline
12 Aug 2022

Lead Editor
Guest Editors

1Institute of Radiation Medicine of Chinese Academy of Medical Science, Tianjin, China

2National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan

3University of Washington Medical Center, Seattle, USA

This issue is now closed for submissions.

Chemo-Radiotherapy for Multimodality Treatment of Tumors 2022

This issue is now closed for submissions.

Description

In recent years, research on how to treat tumors has reached an exciting new era. We are now investigating and applying multimodality treatments with multidisciplinary management.

To improve the quality of life of patients, it is essential for us to not only consider the therapeutic effects. We also need to think how to reduce side-toxic effects on the tumor-surrounding tissues and other organs. Non-operative comprehensive treatment, especially chemo-radiotherapy, has greatly improved the cure rate of patients with advanced cancer. Researchers all over the world have extensively studied tumor chemotherapy, radiotherapy and/or chemoradiotherapy. Further progress is being seen in both basic and clinical research.

The aim of this Special Issue is to bring together original research articles and review articles about advances in tumor chemo-radiotherapy. We hope that this Special Issue also addresses current research providing us new potential strategies for tumor multimodality treatment in basic and clinical settings.

Potential topics include but are not limited to the following:

  • New strategies for clinical tumor chemotherapy or radiotherapy
  • Sensitivity of patients or tumor cells to chemotherapy or radiotherapy
  • Mechanism of tumor tolerance to chemo-radiotherapy
  • Mechanism of radiosensitization in tumor cells
  • Radiosensitizers
  • New biomarkers related to tumor, chemotherapy or radiotherapy
  • Biomaterial development and application for sensitizing chemo-radiotherapy
  • Natural products and tumor therapy
  • Epidemiological study of tumor chemo-radiotherapy
  • Side-toxic effects of radiotherapy and chemotherapy
  • Repair of normal tissue injury caused by radiotherapy
  • Factors influencing the sensitivity of tumor chemo-radiotherapy
  • Cancer stem cells and chemo-radiotherapy
  • Meta analysis of tumor therapy

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 1913900
  • - Research Article

The Clinical Features and Treatment Strategy of Parathyroid Cancer: A Retrospective Analysis

Chen Wang | Kaixue Wen | ... | Yuhao Zhang
  • Special Issue
  • - Volume 2022
  • - Article ID 1164355
  • - Research Article

Effects of Acupuncture on Breast Cancer Patients Taking Aromatase Inhibitors

Qing-ling Qi | Xue Han | Cheng Tang
  • Special Issue
  • - Volume 2022
  • - Article ID 1720696
  • - Research Article

Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis

Long Feng | Ying Wang | ... | Fengming Yi
  • Special Issue
  • - Volume 2022
  • - Article ID 6022981
  • - Research Article

Overcoming Basal Autophagy, Kangai Injection Enhances Cisplatin Cytotoxicity by Regulating FOXO3a-Dependent Autophagic Cell Death and Apoptosis in Human Lung Adenocarcinoma A549/DDP Cells

Huan Zhou | Pengyu Pan | ... | Chun Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 3203965
  • - Research Article

MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer

Jun-Yi Xiang | Xiao-Shan Huang | ... | Yu-Long Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 2043515
  • - Research Article

A Single-Center Treatment Experience of Gamma Knife Radiosurgery for Optic Pathway Glioma

Youlin Ge | Zhiyuan Zhang | ... | Dong Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 7331687
  • - Research Article

Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study

Chenyu Wang | Linzhi Jin | ... | Yaowen Zhang
  • Special Issue
  • - Volume 2022
  • - Article ID 8549532
  • - Review Article

Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated—A Systematic Review

Tito Brambullo | Michele Rosario Colonna | ... | Franco Bassetto
  • Special Issue
  • - Volume 2022
  • - Article ID 4727407
  • - Research Article

Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial

Bo Yang | Xiaofeng Guo | ... | Anlin Hao
  • Special Issue
  • - Volume 2022
  • - Article ID 6455555
  • - Research Article

Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

Chenyu Wang | Xinyu Cheng | ... | Yaowen Zhang
BioMed Research International
 Journal metrics
See full report
Acceptance rate16%
Submission to final decision80 days
Acceptance to publication21 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.